Evidence map›Paper›PMID 40708934›Full record

ReviewFrontiers in oncology2025

A bibliometric analysis of liver cancer bone metastases: advances in mechanisms of occurrence and treatment options.

Jiyong Wei, Yanni Lan, Guipeng Lan, Ronghe Gu

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiyong Wei *Department of Spine Surgery, The First People's Hospital of Nanning, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yanni Lan *Department of Pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, China.
Guipeng LanDepartment of Bone Surgery, The Eight People's Hospital of Nanning, Nanning, China.
Ronghe GuDepartment of Spine Surgery, The First People's Hospital of Nanning, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver cancer ranks as the sixth most frequently diagnosed cancer and is the third leading cause of cancer-related deaths worldwide. Its poor prognosis is mainly due to tumor metastasis. Bone metastasis commonly occurs in the advanced stages of liver cancer and can significantly impact patients' quality of life and prognosis. However, current treatment methods for bone metastasis resulting from liver cancer have significant limitations. This article aims to review the latest research and trends in global studies on bone metastasis associated with liver cancer. Methods: This study used the Web of Science Core Collection to gather 3,347 articles on liver cancer with bone metastasis published from 2004 to 2024.The study applied bibliometric analysis methods, including CiteSpace, VOSviewer, and other tools, to examine countries, institutions, journal authors, keywords, and references. Results: From 2004 to 2024, we collected 3,845 records, including 3,347 articles and 498 reviews from 92 countries. Publications had shown exponential growth, peaking in 2021 with an annual growth rate of 8.3%. The research involved 13,188 organizations. China had the most publications (n=970, 29%), followed by the United States (n=648, 19.4%), Japan (n=317, 9.5%), and Germany (n=228, 6.8%); Canada had a notably higher rate of international collaboration at 44.8%. In total, 830 journals contributed to this research. The most cited journal was "J Clinical Oncol" with 4,275 citations, while "New Engl J Med" had the highest impact factor at 158.5. The research involved 23,710 authors, with Wang, Xin and Zhang, Chao being the authors with the most publications. Wang Z published the first study on this topic in 2007. In 2008, Zhang Y, Wang Y, and Zhang J also began researching this area and have continued to be actively involved since then. The study referenced a total of 79,935 sources, with the paper by Sung H et al., published in CA Cancer J Clin in 2021, achieving the highest citation rate of 42.46. Conclusion: This study systematically summarizes research findings on liver cancer with bone metastasis from 2004 to 2024, It also identifies and predicts global research hotspots and trends. In the future, the molecular mechanisms of liver cancer with bone metastasis will be a major research topic. The expansion of surgical treatment options and the advancement of innovative therapies will benefit more patients.

Indexed as

bibliometricbone metastasisliver cancermolecularresection

Identifiers

PMID40708934
PMCPMC12287054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.